Key Segments:
By Product Type
-
Fibrin-Based Adhesives
-
Cyanoacrylate-Based Adhesives
-
Synthetic and Semi-Synthetic Adhesives
-
Collagen-Based Adhesives
-
Others
By Application
-
General Surgery
-
Cardiovascular Surgery
-
Orthopedic Surgery
-
Cosmetic Surgery
-
Wound Care
By Wound Type
-
External Wound Closure
-
Internal Tissue Sealing
By End-User
-
Hospitals
-
Clinics
-
Ambulatory Surgical Centers
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Baxter International, Johnson & Johnson MedTech, B. Braun, Medtronic, Integra LifeSciences, Advanced Medical Solutions, Artivion, and Becton, Dickinson and Company.
Key opportunities include bioresorbable internal adhesive expansion, room-temperature-stable sealant adoption, emerging-market surgical infrastructure development, and ambulatory surgery growth.
The market is driven by rising surgical procedure volumes, minimally invasive surgery adoption, sutureless closure demand, and expanding bioresorbable adhesive applications.
The Cyanoacrylate-Based Adhesives segment dominated the Surgical Glue Market, accounting for approximately 42% market share.
The North America region dominated the Surgical Glue Market in 2025 with approximately 41.5% share, driven by advanced healthcare infrastructure and high surgical volumes.